Reuters logo
BRIEF-Actinogen Medical ‍receives research & development tax incentive rebate of $1.22 mln
November 14, 2017 / 11:10 PM / a month ago

BRIEF-Actinogen Medical ‍receives research & development tax incentive rebate of $1.22 mln

Nov 15 (Reuters) - Actinogen Medical Ltd:

* ‍Received an research and development tax incentive rebate of $1.22 million for 2016/2017 financial year​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below